HIF1A and neoplasm: Immunohistochemistry (IHC) is currently used to measure the protein level of HIF1A in a hypoxic cancer tissue, but it needs invasive biopsy of the patient’s tumor and lacks reproducibility and consistency due to inter-observer variability.